A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine-Reference-Cited by-同舟云学术

A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine

Published:2024-01-18 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Shah Nitin¹,Ghosh Apurba²,Kumar Kishore³,Dutta Trayambak⁴,Mahajan Manish⁴

Affiliation:

1. Department of Peadiatrics, P.D Hinduja Hospital & Medical Research Centre, Mumbai, India

2. Department of Peadiatrics, Institute of Child Health, Kolkata, India

3. Department of Peadiatrics, CloudNine Group of Hospitals, Bengaluru, India

4. Medical Affairs, Zydus Lifesciences Ltd., Zydus Corporate Park, Ahmedabad, India

Funder

no financial

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2302685

Reference52 articles.

1. Measles, mumps, rubella prevention: how can we do better?

2. Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis

3. Vaidyanathan G. Massive measles outbreak threatens India’s goal to eliminate disease by 2023. 2022 Dec. https://www.nature.com/articles/d41586-022-04480-z.

4. Moving towards the measles and rubella elimination goal in India. 2022 Mar 14. https://www.who.int/india/news/feature-stories/detail/moving-towards-the-measles-and-rubella-elimination-goal-in-india.

5. Govt: 40 kids killed 10 000 affected by measles this year; Maharashtra worst hit. 2022 Dec 20. https://timesofindia.indiatimes.com/india/govt-40-kids-killed-10000-affected-by-measles-this-year-maharashtra-worst-hit/articleshow/96355047.cms.